Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells.
| Autor: | White, D L1, Eadie, L N1, Saunders, V A2, Hiwase, D K1, Hughes, T P1 |
|---|---|
| Zdroj: | Leukemia (08876924). May2013, Vol. 27 Issue 5, p1201-1204. 4p. 1 Chart, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|